International journal of public health · 2025
The CHESS Protocol: A Mixed-Methods Evaluation of an HPV Screening Intervention for Women Living With HIV in Nigeria.
Протокол клинического исследованияСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ogunsola Olabanjo, Gaydos Laura M, Ajayi Oluseye, Dieci Maria, Kaonga Nadi, Awolude Olutosin, Ezemelue Priscilla, Staple Tyree, Salami Kabiru, Idigbe Ifeoma, Ezechi Oliver, Flowers Lisa
Аннотация
OBJECTIVES: In this protocol, we describe a planned intervention to adapt the Mother Mentor (MoMent) peer support program for women living with HIV (WLWH). WLWH face a six-fold higher risk of cervical cancer, yet screening and treatment rates remain low in Nigeria.
METHODS: Using an implementation science approach, we will engage key stakeholders-including ministries of health, NACA, professional bodies, WLWH, Mentor Mothers, healthcare providers, and development partners (e.g., WHO, US CDC, USAID)-through deliberative democracy to adapt and expand MoMent for home-based HPV screening and follow-up treatment. We will pilot the adapted MoMent HIV+HCC program with 1,500 women in 15 health facilities across Nigeria's five geopolitical zones. The RE-AIM framework will guide evaluation of reach, adoption, fidelity, effectiveness, and sustainability.
RESULTS: This study is designed to contribute to WHO's global strategy to eliminate cervical cancer by improving access to home-based screening and care in low-resource settings.
CONCLUSION: Findings will inform national HPV prevention efforts and may drive broader integration into Nigeria's cervical cancer program.
CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov, identifier NCT06751030.
METHODS: Using an implementation science approach, we will engage key stakeholders-including ministries of health, NACA, professional bodies, WLWH, Mentor Mothers, healthcare providers, and development partners (e.g., WHO, US CDC, USAID)-through deliberative democracy to adapt and expand MoMent for home-based HPV screening and follow-up treatment. We will pilot the adapted MoMent HIV+HCC program with 1,500 women in 15 health facilities across Nigeria's five geopolitical zones. The RE-AIM framework will guide evaluation of reach, adoption, fidelity, effectiveness, and sustainability.
RESULTS: This study is designed to contribute to WHO's global strategy to eliminate cervical cancer by improving access to home-based screening and care in low-resource settings.
CONCLUSION: Findings will inform national HPV prevention efforts and may drive broader integration into Nigeria's cervical cancer program.
CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov, identifier NCT06751030.